WHO ICTRP trial
A study to determine if IL-4 is useful as a marker of inflammation of…
ACTRN12605000650695 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Not Recruiting
Key facts
| Trial ID | ACTRN12605000650695 |
|---|---|
| Public title | A study to determine if IL-4 is useful as a marker of inflammation of atherosclerosis |
| Scientific title | A study to determine if IL-4 is useful as a marker of inflammation of atherosclerosis |
| Primary sponsor | Intensive Care Unit, RMH |
| Registry | Australian New Zealand Clinical Trials Registry (ANZCTR) |
| Recruitment status | Not Recruiting |
| Study type | Observational |
| Phase | Not Applicable |
| Countries | Australia |
| Conditions | Atherosclerosis in ischaemic heart disease.; Atherosclerosis in ischaemic heart disease.;Cardiovascular - Other cardiovascular diseases |
| Interventions | This pilot study involves the testing of a new assay to detect IL-4. A once only sample of two mls of blood will be taken from 4 specific groups of patients to test for the presence of IL-4. The cytokine, IL-4, measured by this new assay… |
| Registration date | Oct 17, 2005 |
| Target size | 80 |
| Registry page | anzctr.org.au |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: